<ѻý>Low-Dose Tamoxifen Feasible Option in Breast Cancerѻý> Women appear to prevent recurrence in early stage cancers with 5 mg dosing Dec 06, 2018
<ѻý>Xeloda Disappoints in Early Triple-Negative Breast Cancerѻý> No improvement after standard chemo, though subset may derive some benefit Dec 05, 2018
<ѻý>T-DM1: A New Adjuvant Standard in High-Risk HER2+ Breast Ca?ѻý> Substantial improvements in survival outcomes in KATHERINE trial Dec 05, 2018
<ѻý>SABCS: Translational Before It Was Coolѻý> Growing, evolving while adhering to founding principles Dec 03, 2018
<ѻý>Younger High-Risk Women Benefit From Mammographyѻý> Yields in 30-39 age group at high risk comparable to 40-49 group with average risk Nov 30, 2018
<ѻý>Machine Learning Allows for Low-Dose Gadolinium Contrastѻý> Minimal loss of resolution with 10% Gd dose Nov 30, 2018
<ѻý>Digital Mammograms Show Vulnerability to Cyberattacksѻý> Two out of three radiologists couldn't tell that images were manipulated Nov 28, 2018
<ѻý>Implants May Still Hinder FFDM with Tomosynthesisѻý> Presence of breast implants tied to decreased recall rates and cancer detection rates Nov 26, 2018
<ѻý>Women 75 and Older Benefit from Annual Mammoѻý> Significant number of invasive cancers found Nov 26, 2018
<ѻý>Highlights from Molecular Targets Symposiuimѻý> Breast cancer gene expression, activity in GI, lung, and limited-mutation tumors Nov 16, 2018
<ѻý>AMA Urges Coverage for Added Breast Cancer Screeningѻý> Resolution aimed at women with dense breasts Nov 13, 2018
<ѻý>Survival Bump with Palbociclib in HR+ Breast Cancerѻý> But benefit limited to subgroups; study may have been underpowered Oct 25, 2018
<ѻý>Ethoxyquin Analogue May Prevent Chemotherapy Nerve Damageѻý> Modified agent prevented nerve fiber loss and sensory changes in animal models Oct 22, 2018
<ѻý>PI3K Inhibitor Doubles PFS in HR+/HER2- Breast Cancerѻý> Benefit limited to patients with PIK3CA mutations Oct 22, 2018
<ѻý>No Increase in Late Effects With Weekly RT in Breast Caѻý> 10-year data show low rate of late-onset effects with 28.5 Gy regimen Oct 21, 2018
<ѻý>RT Add-On Boosts Outcomes in 'Low-Risk' DCIS Breast Caѻý> Highest benefit seen in patients who also used tamoxifen Oct 21, 2018
<ѻý>Immunotherapy Wins in Triple-Negative Breast Cancerѻý> Atezolizumab-chemo combo extends PFS, OS in metastatic disease Oct 21, 2018
<ѻý>Nerve Plane Block May Improve Mastectomy Painѻý> Also: obese children and post-surgery pain; patient-controlled epidurals after C-section Oct 16, 2018
<ѻý>Mastectomy Not the Only Option in Extensive DCISѻý> Lumpectomy plus RT viable if risks, benefits are explained Sep 28, 2018
<ѻý>Cardiac Imaging in Breast Ca Driven by Therapyѻý> Mismatch between patient risk, imaging decisions Sep 06, 2018
<ѻý>Flap vs Implant for Breast Reconstruction: How to Chooseѻý> Experts say decision should be personalized Jun 20, 2018
<ѻý>PI3K Inhibitor Has Mixed Results in Advanced Breast Cancerѻý> Modest progression benefit, but substantial side effects, with taselisib Jun 03, 2018
<ѻý>Exercise Cuts Hyperglycemia For Cancer Patients on Chemoѻý> Pilot study hints at other benefits from walking program May 22, 2018
<ѻý>CBT Tops Acupuncture for Treating Insomnia in Cancer Survivorsѻý> But both methods provide alternative to sleeping pills May 17, 2018
<ѻý>Six Months of Trastuzumab Equal to 12 in Breast Caѻý> Similar outcomes and less cardiotoxicity, but more research needed May 16, 2018
<ѻý>BIS Add-On Reduced Lymphedema in Breast Ca Patientsѻý> Bioimpedance spectroscopy plus conservative therapy improved outcomes May 08, 2018
<ѻý>Genetic Test Criteria Often Miss Breast Cancer Riskѻý> Similar cancer-linked mutations in patients who did or did not met test criteria May 07, 2018
<ѻý>How a Pacemaker Made Cancer Doc a Better Clinicianѻý> The wit and wisdom of Larry Norton Mar 30, 2018
<ѻý>Morning Break: Breast Cancer-Schizophrenia Link; FDA on Essure; Rx for Hearing Loss?ѻý> Health news and commentary from around the Web gathered by the ѻý staff Mar 08, 2018
<ѻý>Telemedicine OK for Genetic Testing and Counselingѻý> Trial finds no major difference in psychosocial outcomes Aug 09, 2017
<ѻý>Pearls from: Fatima Cardoso, MD: Part 1ѻý> From clinical inertia to future hope for advanced breast cancer Jul 05, 2017 video
<ѻý>Another CDK4/6 Inhibitor Boosts PFS in Breast Cancerѻý> Abemaciclib-fulvestrant combo for advanced HR+/HER2- disease Jun 08, 2017
<ѻý>Two Anti-HER2 Drugs Slightly Better Than Oneѻý> Patient selection key to addition of pertuzumab to trastuzumab Jun 07, 2017
<ѻý>Genomic Testing Helps Cancer Patients -- When Results are Usedѻý> Also, liquid biopsy can ID drug-responsive tumors Jun 06, 2017
<ѻý>Advanced Ca Patients Benefit from Online Symptom Reportsѻý> Patient-reported outcomes tied to increased survival Jun 05, 2017
<ѻý>Trastuzumab Copycat Has Similar Efficacyѻý> Phase III trial compared substances in early-stage breast cancer Jun 05, 2017
<ѻý>Big Win for PARP Inhibitor in Breast Cancerѻý> PFS boost for HER2-negative, BRCA-mutated disease Jun 05, 2017
<ѻý>Novel Agent Shows Antitumor Activity in TRK-Fusion Cancersѻý> Tumor genetics define treatment approach in early-stage trials Jun 04, 2017
<ѻý>Psychosocial Interventions Help Cancer Patients Copeѻý> Programs focus on lowering fear of recurrence, managing advanced disease Jun 03, 2017
<ѻý>Wise Buy? Proton Beam Therapyѻý> It helps only a few, and at a wildly extravagant cost May 19, 2017